Inflammatory Arthritis Induced by Pembrolizumab in a Patient With Head and Neck Squamous Cell Carcinoma

Introduction: T cell checkpoint inhibitors targeting Programmed cell Death protein-1 (PD-1) have emerged as novel immunotherapy agents showing remarkable efficacy in head and neck squamous cell carcinoma (HNSCC). Despite important clinical benefits, they are associated with side effects that occur a...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Oncol
Autors principals: Spathas, Nikolaos, Economopoulou, Panagiota, Cheila, Myrto, Kotsantis, Ioannis, Fanouriakis, Antonis, Kassara, Dimitra, Psyrri, Amanda
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2018
Matèries:
Oncology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6168664/
https://ncbi.nlm.nih.gov/pubmed/30319973
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2018.00409
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars